microdosing tirzepatide doses Microdosing tirzepatide chart: complete week-by-week

The authors conclude: In the STEP TEENS trial, treatment with semaglutide 2.4 mg once weekly for 68 weeks was associated with a significant reduction of levels of the liver enzyme alanine aminotransferase compared with placebo. Dr Weghuber adds: Fatty liver disease is the most frequent liver disease in adolescents with no drug therapy currently available

This protocol helps to minimize side effects, and monitor how well you tolerate the medication

If you monitor glucose, look for patterns rather than single readings

You may experience a temporary increase in nausea, reduced appetite, or mild gastrointestinal symptoms if your body is sensitive to concentration spikes

doi:10.1056/NEJMoa0806470 28

The risk of overreacting is minor embarrassment